An exploratory phase II, randomised, double-blind, placebo-controlled, parallel-group study investigating the efficacy and safety of Sepranolone in women with menstrual migraine
Latest Information Update: 28 Jul 2021
At a glance
- Drugs Sepranolone (Primary)
- Indications Menstrual migraine
- Focus Proof of concept; Therapeutic Use
- Sponsors Asarina Pharma
Most Recent Events
- 22 Jul 2021 Status changed from active, no longer recruiting to completed.
- 29 Apr 2021 This trial has been completed in Sweden (End Date: 06 Apr 2021), according to European Clinical Trials Database record.
- 25 Apr 2021 This trial has been completed in Sweden (End Date: 06 Apr 2021), according to European Clinical Trials Database record.